id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-3159-0006,FDA,FDA-2015-E-3159,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-09-21T04:00:00Z,2017,9,2017-09-21T04:00:00Z,,2017-09-21T13:13:01Z,,0,0,0900006482b6937e
FDA-2015-E-3159-0005,FDA,FDA-2015-E-3159,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-12-13T05:00:00Z,2016,12,2016-12-13T05:00:00Z,,2016-12-13T16:45:13Z,,0,0,0900006482401462
FDA-2015-E-3159-0004,FDA,FDA-2015-E-3159,Determination of Regulatory Review Period for Purposes of Patent Extension; TRUMENBA,Notice,Determinations,2016-12-02T05:00:00Z,2016,12,2016-12-02T05:00:00Z,2017-06-01T03:59:59Z,2016-12-02T17:20:09Z,2016-28916,0,0,09000064823db1ad
FDA-2015-E-3159-0003,FDA,FDA-2015-E-3159,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T15:46:30Z,,0,0,0900006481cd58d6
FDA-2015-E-3159-0002,FDA,FDA-2015-E-3159,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-08-27T04:00:00Z,2015,8,2015-08-27T04:00:00Z,,2015-08-27T18:44:38Z,,0,0,0900006481c3e4c4
FDA-2015-E-3159-0001,FDA,FDA-2015-E-3159,Patent Extension Application from Pfizer Inc. (on behalf of Wyeth Holding LLC),Other,Application,2015-08-27T04:00:00Z,2015,8,2015-08-27T04:00:00Z,,2015-08-27T18:44:31Z,,0,0,0900006481c3e4c6